In studies of calcium metabolism in 13 unselected patients with untreated sarcoidosis all were normocalcaemic but five had hypercalcuria. All had normal renal function. Calcium absorption was indexed by a double isotope test. 45Ca hyperabsorption occurred in six patients. Ten kinetic studies were carried out with 47Ca and in six bone turnover was increased. 45Ca absorption correlated well with the calculated bone uptake rate of calcium, and with urine calcium excretion.
Introduction
The almost constant finding of a low faecal calcium content in external balance studies'-9 has led to the widely held belief that hyperabsorption is the main cause of hypercalcaemia and hypercalcuria in sarcoidosis."'' A few patients with raised serum and urine calcium levels have not shown hyperabsorption," 12 however, or had a low calcium intake," which suggests that increased bone resorption might be an additional contributory factor. Increased bone turnover has been shown by kinetic studies in three hypercalcaemic patients.9 '3 There have been few studies of calcium metabolism in normocalcaemic sarcoidosis." We investigated whether hyperabsorption of calcium was a specific feature of those cases with hypercalcaemia or whether a more widespread abnormality was generally present in sarcoidosis and thus acted as a marker of disease activity. We also made kinetic measurements of calcium turnover in the bones to investigate the possibility of abnormal bone metabolism as well. All the patients we studied proved to be normocalcaemic. Only one case of hypercalcaemia has occurred among 66 sarcoid patients seen at the chest clinic over
Patients and methods
Thirteen consecutive patients (aged 23-53 years) with untreated sarcoidosis, diagnosed and followed-up at the chest clinic, Hammersmith Hospital, were included in this study when their general condition was being assessed. In 10 patients the diagnosis was supported by a positive biopsy finding or positive Kveim test, or both, while in the other three patients (cases 2, 5, and 13) the diagnosis was made on clinical and radiological grounds. One patient (case 4) also had Paget's disease of the pelvis, so no data that might reflect his bone turnover will be shown.
Four patients were studied twice. The second time two patients were on steroid treatment; one (case 3) received prednisone 1 mg/day, having been started on 20 mg/day four months before, and the other (case 10) received prednisone 10 mg/day. We also included the results of balance studies that had been carried out in two earlier patients. They had had histologically proved sarcoidosis and had been referred for investigation and treatment of hypercalcaemia. Their blood urea concentrations, as in the normocalcaemic series, were normal. CALCIUM ISOTOPE STUDIES Bone turniover was calculated by a "turnover-difference" method based on a single compartment model,'4 using an intravenous injection of 10 ,lCi of 47Ca. The results reported here are the exchangeable calcium pool size and the daily bone uptake rate of calcium. Both values were expressed in plasma units, which are units of volume corrected for body weight,'5 and the uptake rate was also expressed in mmol calcium/kg body weight (2 mEq/kg).
Absorption of 45Ca was indexed by a double isotope method'6 using simultaneous administration of 10 ,uCi of 45Ca orally and 10 ,uCi of 47Ca intravenously, the latter also being used for the above-mentioned kinetic studies. The results reflect the percentage of the oral tracer dose that has been absorbed. Our observed normal range, in 20 agematched normal volunteers was 32-650o, with a mean of 490o .
Endogenous faecal calcium-that is, the unreabsorbed fraction of digestive juice calcium, was calculated from the amount of intravenously injected 47Ca excreted in the faeces over six to nine days. 17 18 Our normal range, obtained from 11 normal subjects, gave a range of 3 4-5-45 mmol calcium/day.'9 The calcium intake at home was estimated by diet history and using analytical food tables.'0 BALANCE STUDIES Calcium and nitrogen balances were carried out in the metabolic unit.2' Carmine red, but no inert faecal marker, was used. The validity of the three-day pooled faecal collection was checked by regularity of the nitrogen content.
ANALYTICAL METHODS
Serum and urinary calcium, inorganic phosphate, alkaline phosphatase, creatinine, and blood urea concentrations were measured in several samples in each patient by standard autoanalyser techniques."
For the two balance studies, serum, urinary, and faecal calcium were estimated by flame spectrophotometry, the latter performed on a perchloric acid digest.2
Results
The biochemical data and the results of calcium absorption and kinetic studies are shown in the Although all values were normal they were all towards the lower limit of the normal range. In contrast the mean serum calcium levels for the same patients were in the upper half of the normal range.
Intestinal absorption of 45Ca, expressed as percentage absorption of the oral dose, was raised in six patients (fig 1) . The mean value for the sarcoid group (61-5°,) was significantly higher than the mean (490o) for the 20 controls (P = 0 02). Similar results were obtained when the individual daily calcium intake was taken into account by multiplying fractional absorption by intake. The urinary calcium output was proportional (r = 0-70; P < 001) to absorption (fig 2) .
The isotopically determined bone uptake rate was raised in six of the 10 patients in whom it was measured; two also showed a raised exchangeable pool. Bone turnover correlated well with both-the serum alkaline phosphatase levels (r = 0-62; P < 0 05) and with the 45Ca absorption (r = 0-80; P <0 001) (figs 3 and 4). Bone turnover in turn correlated well (r = 0-65; P < 0.05) with urine calcium values. The endogenous faecal calcium output was essentially normal in this series.
The balance studies previously carried out in two patients with hypercalcaemic sarcoidosis and normal renal function both showed a negative calcium balance, which became even more negative under corticosteroid treatment (fig 5) . This is typical of the findings in 16 out of 19 such studies we reviewed from nine published reports. 
Discussion
This study shows that calcium metabolism is abnormal in some sarcoid patients, even when the serum calcium concentration is normal. Thus, hyperabsorption by the gut is often a feature in normocalcaemic sarcoidosis just as in hypercalcaemic sarcoidosis and may largely determine the urine output in patients on a normal calcium intake, as these are clearly correlated (fig 2) . It has been speculated that the high net absorption so often reported in balance studies might be caused by a subnormal endogenous faecal calcium output,24 but neither we nor Miller et al13 found this. A clear tendency to increased bone turnover was shown by the calcium kinetic studies and supported by the correlation with the serum alkaline phosphatase concentration (fig 3) . Presumably this is an effect on bone that is independent of the gut effect. But the fact that the gut and bone abnormalities were found to be proportional (fig 4) , might mean that they are due to a common metabolic factor. The hypercalcuria may be a third effect of this factor, in correlating with both intestinal absorption (r=0-70) and bone turnover (r=0-65); it might also simply be a consequence of the increased renal calcium load.
No published reports have indicated the possible nature of the skeletal involvement leading to increased turnover, and there has been no systematic study of bone histology using quantitative techniques. It seems highly unlikely that the mechanism is bone destruction by sarcoid granulomata, because radiologically evident bone lesions and hypercalcaemia rarely coexist,25 26 and no relation between these two aspects of the disease has been found.4 217-9 The fact that hypercalcaemia has been reported," even in the presence of a very low calcium intake, points to a substantial increase in skeletal resorption as the calcium source in such severely affected patients.
Parathyroid hormone does not seem to be responsible. The serum parathyroid hormone levels were found to be too low to measure by Cushard et al,30 while we inferred a reduced biological effect of the hormone from the rather low phosphate excretion index values found. Lebacq31 reported similar findings. The fairly common finding of hypercalcuria in sarcoidosis32-34 would also be consistent with reduced parathyroid hormone action on the renal tubules.
An abnormality in vitamin D metabolism has long been suspected,' 2 4 35-37 but no evidence was found of excessive formation of either of the biologically active metabolites 25hydroxycholecalciferol, or 1, 25-dihydroxycholecalciferol.'8 As the bioassayed antirachitic activity in the serum of hypercalcaemic sarcoid patients has been within the normal range, or even lower, 39 40 the abnormality is probably located at the cellular level, presenting as a target organ hypersensitivity affecting the gut' 8 36 40 and bone. 912 A discriminative effect of corticosteroids on gut and bone9 explains the immediate rise in faecal calcium output and the delayed fall in urine calcium, the balance becoming transiently more negative (fig 5) . The failure of hypercalcaemia in patients with sarcoidosis to respond to steroid treatment suggests coexistent hyperparathyroidism." 4
Little has been reported about the natural history of the disturbance in calcium metabolism. In our series there seemed to be a positive correlation, within the first year, between duration of the disease and the severity of the effect on bone turnover. This is corroborated by the inverse correlation with the increase in the erythrocyte sedimentation rate,45 which is highest in the initial phase of the inflammatory process and progressively returns to normal within a few months.
The effect on bone seems to level off eventually (case 7). Similar conclusions can be drawn from the progressive fall of the total hydroxyproline excretion, which is raised in patients with short-lived disease but becomes normal in cases of longstanding sarcoidosis." Presumably the phase of increased bone resorption, as indicated by hydroxyproline excretion, is relatively short, and frank demineralisation of the skeleton is exceptional. 47 48 Our general conclusion is that metabolic abnormalities are unexpectedly common in sarcoidosis. Presumably only the few patients who are most severely affected develop hypercalcaemia.
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Summary
To compare findings in a hospital trial of hypotensive drugs with those in a general practice trial several patients with mild hypertension were studied at the same time in hospital and in general practice. They received bendrofluazide and potassium chloride or bendrofluazide, potassium chloride, and reserpine according to a double-blind crossover protocol, and blood biochemical values were studied over eight weeks and six months. When reserpine was withdrawn from nine women they followed a modified protocol comparing bendrofluazide and potassium chloride with potassium chloride alone.
Introduction
Clinical trials of antihypertensive drugs are usually carried out in hospitals, where strict control of conditions can be ensured. Difficulty in recruiting enough patients in hospital and a feeling that less artificiality attaches to studies conducted away from the wards or outpatient clinics have led recently to many more trials being performed exclusively in general practice.1 2 So far as we know no comparison has ever been made of results obtained in the same patient population studied at the same time both in general practice and the hospital clinic. This doubleblind crossover study was designed to provide such a comparison using well-established treatment for mild hypertension. In most clinical trials short-term changes in the patients' blood chemistry are reported, from which long-term conclusions are sometimes drawn. As a secondary objective in this study we have examined and compared the changes in chemical values in the plasma (including plasma renin activity (PRA) ) over both short (eight weeks) and longer periods (six months) of treatment.
